MONOCLONAL ANTIBODY FOR CANCER TREATMENT (Q3133637)

From EU Knowledge Graph
Revision as of 08:00, 9 October 2021 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the infer coords bot - inferring coordinates from location)
Jump to navigation Jump to search
Project Q3133637 in Spain
Language Label Description Also known as
English
MONOCLONAL ANTIBODY FOR CANCER TREATMENT
Project Q3133637 in Spain

    Statements

    country
    Spain
    0 references
    EU contribution
    2,812,369.5 Euro
    0 references
    budget
    5,624,739.0 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    16 February 2015
    0 references
    end time
    14 December 2015
    0 references
    beneficiary name (string)
    ALTHIA HEALTH S.L.
    0 references
    beneficiary
    Q3133636
    0 references
    programme
    Madrid - ERDF
    0 references
    coordinate location

    40°25'0.12"N, 3°42'12.89"W
    0 references
    postal code
    28079
    0 references
    summary
    VALIDACIÓN DE UN ANTICUERPO MONOCLONAL PARA LA DETECCIÓN Y TRATAMIENTO DE CÉLULAS MADRE DEL CÁNCER EN TUMORES DE CEREBRO (Spanish)
    0 references
    VALIDATION OF A MONOCLONAL ANTIBODY FOR THE DETECTION AND TREATMENT OF CANCER MOTHER CELLS IN BRAIN TUMORS (English)
    0 references
    location (string)
    Madrid
    0 references

    Identifiers

    Spanish Kohesio ID
    DGEPF/01/21/002-17/18
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q3133637&oldid=12445307"